Updated Jul 16, 2026
Resnick Joshua has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
Joshua Resnick is a corporate director with a recorded board role at Sionna Therapeutics, Inc. The provided SEC filing context identifies him as a Director of Sionna Therapeutics, Inc. as of June 18, 2026. The public biographical information available from the context is limited to this director role.
| Role | Director |
|---|---|
| Notability | 20/100 |
Joshua Resnick is a corporate director with a recorded board role at Sionna Therapeutics, Inc. The provided SEC filing context identifies him as a Director of Sionna Therapeutics, Inc. as of June 18, 2026. The public biographical information available from the context is limited to this director role.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Resnick Joshua profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.